Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Satisfaction of Specific Modes Related to Physical Activity in People Living With Type 1 Diabetes and Using an Hybrid Closed-loop System (BF-ACT)

27. april 2026 opdateret af: University Hospital, Grenoble

The BF-ACT study is a single-center, non-interventional (RIPH3) descriptive study conducted at CHU Grenoble Alpes. It aims to evaluate the satisfaction of adults with type 1 diabetes using closed-loop insulin delivery systems, specifically regarding the "physical activity mode" designed to adapt insulin delivery during exercise.

Although physical activity is essential for managing type 1 diabetes, it remains challenging due to the risk of hypoglycemia. Closed-loop systems have improved glucose control, but their effectiveness during exercise depends on multiple factors, and their real-life use can be complex. Currently, little is known about patient satisfaction and experience with these specific modes.

The study will collect data through a self-administered questionnaire, distributed to eligible patients (≥18 years old, with type 1 diabetes, using a closed-loop system for at least 4 months). The primary outcome is the satisfaction score based on the questionnaire. Secondary objectives include describing physical activity perception, usage of the activity mode, and comparing users versus non-users.

Approximately up to 900 patients may be included over a 4-month recruitment period. Clinical and glucose monitoring data will also be collected from medical records. The results are expected to improve patient education, device usability, and support for physical activity in people living with type 1 diabetes.

Studieoversigt

Status

Rekruttering

Betingelser

Intervention / Behandling

Undersøgelsestype

Interventionel

Tilmelding (Anslået)

900

Fase

  • Ikke anvendelig

Kontakter og lokationer

Dette afsnit indeholder kontaktoplysninger for dem, der udfører undersøgelsen, og oplysninger om, hvor denne undersøgelse udføres.

Studiekontakt

Studiesteder

      • Grenoble, Frankrig
        • Rekruttering
        • Chu Grenoble Alpes
        • Kontakt:

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

  • Voksen
  • Ældre voksen

Tager imod sunde frivillige

Ingen

Beskrivelse

Inclusion Criteria

  • Age ≥ 18 years
  • Patient living with type 1 diabetes
  • Patient using a closed-loop system for at least 4 months
  • Patient followed by a diabetologist in our center

Exclusion criteria

  • People opposed to the research
  • People protected by the law

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Primært formål: Andet
  • Tildeling: N/A
  • Interventionel model: Enkelt gruppeopgave
  • Maskning: Ingen (Åben etiket)

Våben og indgreb

Deltagergruppe / Arm
Intervention / Behandling
Andet: Only 1 arm = patient treated with AID systems
Administration of 1 questionnar to investigate the satisfaction with the physical activity mode of closed-loop systems among people living with type 1 diabetes.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Satisfaction score
Tidsramme: Baseline
Part C, D and E of the questionnar
Baseline

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Describe the perception of physical activity within the study population
Tidsramme: Baseline
Part A of the questionnar
Baseline
Describe the proportion of individuals using the physical activity mode in our study
Tidsramme: Baseline
Part B of the questionnar
Baseline
Describe satisfaction with the mode in relation to the physical activities performed by patients
Tidsramme: Baseline
Part F of the questionnar
Baseline
Describe overall satisfaction with the "physical activity" mode
Tidsramme: Baseline
Part G of the questionnar
Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

HbA1c (%)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Type of closed-loop system

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Duration of use of the closed-loop system

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Time spent in closed-loop mode

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Duration of type 1 diabetes

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Age

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Sex

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

Body Mass Index (BMI)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

  • Time in Range (TIR) 70-180 mg/dL
  • Time in Tight Range (TITR) 70-140 mg/dL
  • Time Above Range (TAR) > 180 mg/dL and > 250 mg/dL
  • Time Below Range (TBR) < 70 mg/dL and < 54 mg/dL
Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

- Mean glucose (mg/dL)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

- Glucose Management Index (GMI)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

- Coefficient of Variation (CV, in %)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

- Glycemia Risk Index (GRI)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

- Total daily insulin dose (IU/day)

Baseline
Compare populations who use the physical activity mode with those who do not use it
Tidsramme: Baseline

Comparison based on several parameters to describe the two populations at the time of questionnaire completion:

CGM data over the 15 days prior to questionnaire completion:

- Percentage of use of the physical activity mode

Baseline

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Faktiske)

21. april 2026

Primær færdiggørelse (Anslået)

31. august 2026

Studieafslutning (Anslået)

31. december 2026

Datoer for studieregistrering

Først indsendt

20. april 2026

Først indsendt, der opfyldte QC-kriterier

27. april 2026

Først opslået (Faktiske)

5. maj 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

5. maj 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

27. april 2026

Sidst verificeret

1. april 2026

Mere information

Begreber relateret til denne undersøgelse

Plan for individuelle deltagerdata (IPD)

Planlægger du at dele individuelle deltagerdata (IPD)?

UBESLUTET

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner